Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement

doi:10.1001/jama.2020.0435

Practice Guideline

. 2020 Feb 25;323(8):757-763.

doi: 10.1001/jama.2020.0435.

Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force; Douglas K Owens^{1

2}, Karina W Davidson³, Alex H Krist^{4

5}, Michael J Barry⁶, Michael Cabana⁷, Aaron B Caughey⁸, Chyke A Doubeni⁹, John W Epling Jr¹⁰, Martha Kubik¹¹, C Seth Landefeld¹², Carol M Mangione¹³, Lori Pbert¹⁴, Michael Silverstein¹⁵, Melissa A Simon¹⁶, Chien-Wen Tseng^{17

18}, John B Wong¹⁹

Affiliations

¹ Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
² Stanford University, Stanford, California.
³ Feinstein Institute for Medical Research, Northwell Health, Manhasset, New York.
⁴ Fairfax Family Practice Residency, Fairfax, Virginia.
⁵ Virginia Commonwealth University, Richmond.
⁶ Harvard Medical School, Boston, Massachusetts.
⁷ University of California, San Francisco.
⁸ Oregon Health & Science University, Portland.
⁹ Mayo Clinic, Rochester, Minnesota.
¹⁰ Virginia Tech Carilion School of Medicine, Roanoke.
¹¹ Temple University, Philadelphia, Pennsylvania.
¹² University of Alabama at Birmingham.
¹³ University of California, Los Angeles.
¹⁴ University of Massachusetts Medical School, Worcester.
¹⁵ Boston University, Boston, Massachusetts.
¹⁶ Northwestern University, Evanston, Illinois.
¹⁷ University of Hawaii, Honolulu.
¹⁸ Pacific Health Research and Education Institute, Honolulu, Hawaii.
¹⁹ Tufts University School of Medicine, Boston, Massachusetts.

PMID: 32096858
DOI: 10.1001/jama.2020.0435

Practice Guideline

Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force et al. JAMA. 2020.

. 2020 Feb 25;323(8):757-763.

doi: 10.1001/jama.2020.0435.

Authors

Affiliations

¹ Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
² Stanford University, Stanford, California.
³ Feinstein Institute for Medical Research, Northwell Health, Manhasset, New York.
⁴ Fairfax Family Practice Residency, Fairfax, Virginia.
⁵ Virginia Commonwealth University, Richmond.
⁶ Harvard Medical School, Boston, Massachusetts.
⁷ University of California, San Francisco.
⁸ Oregon Health & Science University, Portland.
⁹ Mayo Clinic, Rochester, Minnesota.
¹⁰ Virginia Tech Carilion School of Medicine, Roanoke.
¹¹ Temple University, Philadelphia, Pennsylvania.
¹² University of Alabama at Birmingham.
¹³ University of California, Los Angeles.
¹⁴ University of Massachusetts Medical School, Worcester.
¹⁵ Boston University, Boston, Massachusetts.
¹⁶ Northwestern University, Evanston, Illinois.
¹⁷ University of Hawaii, Honolulu.
¹⁸ Pacific Health Research and Education Institute, Honolulu, Hawaii.
¹⁹ Tufts University School of Medicine, Boston, Massachusetts.

PMID: 32096858
DOI: 10.1001/jama.2020.0435

Abstract

Importance: Dementia (also known as major neurocognitive disorder) is defined by a significant decline in 1 or more cognitive domains that interferes with a person's independence in daily activities. Dementia affects an estimated 2.4 to 5.5 million individuals in the United States, and its prevalence increases with age.

Objective: To update its 2014 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a review of the evidence on screening for cognitive impairment, including mild cognitive impairment and mild to moderate dementia, in community-dwelling adults, including those 65 years or older residing in independent living facilities.

Population: This recommendation applies to community-dwelling older adults 65 years or older, without recognized signs or symptoms of cognitive impairment.

Evidence assessment: The USPSTF concludes that the evidence is lacking, and the balance of benefits and harms of screening for cognitive impairment cannot be determined.

Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for cognitive impairment in older adults. (I statement).

PubMed Disclaimer

Comment in

Evidence Still Lacking for Recommendation of Screening for Cognitive Impairment in Older Adults.
Brayne C. Brayne C. JAMA Intern Med. 2020 Apr 1;180(4):483-484. doi: 10.1001/jamainternmed.2019.7522. JAMA Intern Med. 2020. PMID: 32096825 No abstract available.
Issues and Questions Surrounding Screening for Cognitive Impairment in Older Patients.
Petersen RC, Yaffe K. Petersen RC, et al. JAMA. 2020 Feb 25;323(8):722-724. doi: 10.1001/jama.2019.22527. JAMA. 2020. PMID: 32096831 Free PMC article. No abstract available.
Insufficient evidence for benefits/harms of cognitive impairment screening in asymptomatic older adults.
Aung K, Htay T. Aung K, et al. Ann Intern Med. 2020 Jul 21;173(2):JC2. doi: 10.7326/ACPJ202007210-003. Ann Intern Med. 2020. PMID: 32687759

Summary for patients in

Screening for Cognitive Impairment in Older Adults.
Jin J. Jin J. JAMA. 2020 Feb 25;323(8):800. doi: 10.1001/jama.2020.0583. JAMA. 2020. PMID: 32096853 No abstract available.

Cited by

Prevalence of Unrecognized Cognitive Impairment in Federally Qualified Health Centers.
Kulshreshtha A, Parker ES, Fowler NR, Summanwar D, Ben Miled Z, Owora AH, Galvin JE, Boustani MA. Kulshreshtha A, et al. JAMA Netw Open. 2024 Oct 1;7(10):e2440411. doi: 10.1001/jamanetworkopen.2024.40411. JAMA Netw Open. 2024. PMID: 39436648 Free PMC article.
Cognivue Clarity characterizes mild cognitive impairment and Alzheimer's disease in biomarker confirmed cohorts in the Bio-Hermes Study.
Galvin JE, Kleiman MJ, Estes PW, Harris HM, Fung E. Galvin JE, et al. Sci Rep. 2024 Oct 18;14(1):24519. doi: 10.1038/s41598-024-75304-5. Sci Rep. 2024. PMID: 39424626 Free PMC article.
Annual Wellness Visits and Early Dementia Diagnosis Among Medicare Beneficiaries.
Tzeng HM, Raji MA, Shan Y, Cram P, Kuo YF. Tzeng HM, et al. JAMA Netw Open. 2024 Oct 1;7(10):e2437247. doi: 10.1001/jamanetworkopen.2024.37247. JAMA Netw Open. 2024. PMID: 39378037 Free PMC article.
Identifying individuals at high risk for dementia in primary care: Development and validation of the DemRisk risk prediction model using routinely collected patient data.
Reeves D, Morgan C, Stamate D, Ford E, Ashcroft DM, Kontopantelis E, Van Marwijk H, McMillan B. Reeves D, et al. PLoS One. 2024 Oct 4;19(10):e0310712. doi: 10.1371/journal.pone.0310712. eCollection 2024. PLoS One. 2024. PMID: 39365767 Free PMC article.
Hearing Loss, Hearing Aids, and Cognition.
Grenier B, Berr C, Goldberg M, Jouven X, Zins M, Empana JP, Lisan Q. Grenier B, et al. JAMA Netw Open. 2024 Oct 1;7(10):e2436723. doi: 10.1001/jamanetworkopen.2024.36723. JAMA Netw Open. 2024. PMID: 39352700 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement

Affiliations

Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement

Authors

Affiliations

Abstract

Comment in

Summary for patients in

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Abstract

Comment in

Summary for patients in

Similar articles

Cited by

Publication types

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Medical